Evaluation of Combination of Microneedling with Tacrolimus in the Treatment of Stable Vitiligo

Saurabh Sharma, Parwaaz Matharoo, R. Bassi
{"title":"Evaluation of Combination of Microneedling with Tacrolimus in the Treatment of Stable Vitiligo","authors":"Saurabh Sharma, Parwaaz Matharoo, R. Bassi","doi":"10.29021/spdv.79.3.1336","DOIUrl":null,"url":null,"abstract":"Introduction: Vitiligo is an amelanotic disorder that can manifest as localized patches to near total body depigmentation. It is considered a cosmetic disease but it is accompanied by extensive psychological effects. Multiple treatments have been tried until now but no single method has achieved the desired response. Tacrolimus is frequently used for vitiligo treatment with few adverse effects. Microneedling is a newer modality of therapeutic wounding that augments drug absorption. Combination of microneedling and tacrolimus have been tried to improve the repigmentation response in vitiligo. Our objective was to assess the safety and efficacy of this combined modality. \nMethods: Forty patients were subjected to combination of tacrolimus 0.1% ointment and microneedling at 2 week intervals for maximum 10 sessions with a follow-up period of 6 months. Assessment was based on grading of repigmentation and clinical improvement according to vitiligo noticeability scale. \nResults: Excellent repigmentation was observed in 30% cases. Improvement was significantly higher in lesions present on the head and neck. Mucosal vitiligo also showed good to excellent response. No severe side effects were reported. No complications or recurrences were observed during the follow-up period. \nConclusion: Combination of microneedling and tacrolimus was found to be safe and efficacious in the treatment of stable vitiligo.","PeriodicalId":238976,"journal":{"name":"Journal of the Portuguese Society of Dermatology and Venereology","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Portuguese Society of Dermatology and Venereology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29021/spdv.79.3.1336","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Vitiligo is an amelanotic disorder that can manifest as localized patches to near total body depigmentation. It is considered a cosmetic disease but it is accompanied by extensive psychological effects. Multiple treatments have been tried until now but no single method has achieved the desired response. Tacrolimus is frequently used for vitiligo treatment with few adverse effects. Microneedling is a newer modality of therapeutic wounding that augments drug absorption. Combination of microneedling and tacrolimus have been tried to improve the repigmentation response in vitiligo. Our objective was to assess the safety and efficacy of this combined modality. Methods: Forty patients were subjected to combination of tacrolimus 0.1% ointment and microneedling at 2 week intervals for maximum 10 sessions with a follow-up period of 6 months. Assessment was based on grading of repigmentation and clinical improvement according to vitiligo noticeability scale. Results: Excellent repigmentation was observed in 30% cases. Improvement was significantly higher in lesions present on the head and neck. Mucosal vitiligo also showed good to excellent response. No severe side effects were reported. No complications or recurrences were observed during the follow-up period. Conclusion: Combination of microneedling and tacrolimus was found to be safe and efficacious in the treatment of stable vitiligo.
微针联合他克莫司治疗稳定型白癜风疗效评价
简介:白癜风是一种无色性疾病,可以表现为局部斑块到接近全身的色素沉着。它被认为是一种美容疾病,但它伴随着广泛的心理影响。到目前为止,已经尝试了多种治疗方法,但没有一种方法能达到预期的效果。他克莫司常用于治疗白癜风,几乎没有不良反应。微针是一种较新的治疗损伤方式,可以增加药物吸收。微针联合他克莫司可改善白癜风患者的色素重沉着反应。我们的目的是评估这种联合方式的安全性和有效性。方法:40例患者采用0.1%他克莫司软膏联合微针治疗,间隔2周,最多10次,随访6个月。根据白癜风显著性量表进行再色素沉着分级和临床改善。结果:30%的患者有良好的色素沉着。头颈部病变的改善明显更高。粘膜白癜风也表现出良好到极好的疗效。没有严重副作用的报道。随访期间无并发症及复发。结论:微针联合他克莫司治疗稳定型白癜风安全有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信